Capital Fund Management S.A. Nektar Therapeutics Call Options Transaction History

Capital Fund Management S.A.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2018 Feb 13, 2019	BUY	$30.43 - $56.65 $124,763 - $232,265	4,100 Added 39.05%	14,600 $480,000
Q3 2018 Nov 14, 2018	SELL	$46.46 - $68.49 $2.28 Million - $3.36 Million	-49,000 Reduced 82.35%	10,500 $640,000
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $2.09 Million - $4.72 Million	45,200 Added 316.08%	59,500 $2.91 Million
Q1 2018 May 15, 2018	BUY	$57.4 - $108.44 $820,820 - $1.55 Million	14,300 New	14,300 $1.52 Million

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.